516
Participants
Start Date
July 31, 2014
Primary Completion Date
September 30, 2014
Study Completion Date
June 30, 2015
Training on BF Spiromax followed by SYMBICORT Turbohaler
Training with a placebo comparator: Budesonide Formoterol (BF) Spiromax® device using a 6-level system to examine the number of levels required to acquire mastery of device at baseline and maintenance and mastery at 4 and 8 weeks after initial training.
Training on SYMBICORT Turbohaler followed by BF Spiromax
Training with a placebo comparator: SYMBICORT Turbohaler® device using a 6-level system to examine the number of levels required to acquire mastery of device at baseline and maintenance and mastery at 4 and 8 weeks after initial training.
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY
University of Sydney
OTHER
Woolcock Institute of Medical Research
OTHER
University of Technology, Sydney
OTHER
The University of New South Wales
OTHER
Research in Real-Life Ltd
NETWORK